Current:Home > MyKroger, Albertsons — still hoping to merge — agree to sell more stores to satisfy regulators -Quantum Capital Pro
Kroger, Albertsons — still hoping to merge — agree to sell more stores to satisfy regulators
Surpassing Quant Think Tank Center View
Date:2025-04-10 15:38:34
Supermarket chains Kroger and Albertsons said Monday they will sell more of their stores in an effort to quell the federal government’s concerns about their proposed merger.
The companies now plan to sell 579 Kroger and Albertsons stores in markets where they overlap to C&S Wholesale Grocers, a New Hampshire grocery supplier and operator, for $2.9 billion. Under the initial divestiture plan, announced in September, C&S had planned to purchase 413 stores for $1.9 billion.
It’s unclear if the new plan will satisfy regulators. In February, the U.S. Federal Trade Commission sued to block the $24.6 billion merger between the grocery giants, saying the lack of competition would lead to higher grocery prices and lower wages for workers.
The FTC also said the initial plan to divest 413 stores to C&S was “inadequate” and would give C&S a hodgepodge of unconnected stores and brands, leaving it ill-equipped to compete with a combined Kroger and Albertsons.
Under the updated plan, Kroger would sell its Haggen banner to C&S. C&S would also license the Albertsons banner in California and Wyoming and the Safeway banner in Arizona and Colorado. C&S would also get access to some private-label brands in the stores. Under the proposal, C&S would keep all of the stores open and honor any labor agreements.
“We are confident this expanded divestiture package will provide the stores, supporting assets and expert operators needed to ensure these stores continue to successfully serve their communities for many generations to come,” C&S CEO Eric Winn said in a statement.
Kroger and Albertsons announced their planned merger in October 2022. The companies say it’s necessary so they can better compete with Walmart, Amazon and other big rivals.
veryGood! (4157)
Related
- Sarah J. Maas books explained: How to read 'ACOTAR,' 'Throne of Glass' in order.
- When is it OK to make germs worse in a lab? It's a more relevant question than ever
- Ohio to Build First Offshore Wind Farm in Great Lakes, Aims to Boost Local Industry
- Justin Long and Kate Bosworth Are Married One Month After Announcing Engagement
- Don't let hackers fool you with a 'scam
- Ohio to Build First Offshore Wind Farm in Great Lakes, Aims to Boost Local Industry
- How our perception of time shapes our approach to climate change
- A single-shot treatment to protect infants from RSV may be coming soon
- New Mexico governor seeks funding to recycle fracking water, expand preschool, treat mental health
- Oversight Committee subpoenas former Hunter Biden business partner
Ranking
- See you latte: Starbucks plans to cut 30% of its menu
- Tipflation may be causing tipping backlash as more digital prompts ask for tips
- Can Trump still become president if he's convicted of a crime or found liable in a civil case?
- S Club 7 Shares Tearful Update on Reunion Tour After Paul Cattermole’s Death
- NHL in ASL returns, delivering American Sign Language analysis for Deaf community at Winter Classic
- U.S. announces $325 million weapons package for Ukraine as counteroffensive gets underway
- Why Chris Pratt's Mother's Day Message to Katherine Schwarzenegger Is Sparking Debate
- Trump’s EPA Pick: A Climate Denialist With Disdain for the Agency He’ll Helm
Recommendation
Jorge Ramos reveals his final day with 'Noticiero Univision': 'It's been quite a ride'
Scant obesity training in medical school leaves docs ill-prepared to help patients
As she nursed her mom through cancer and dementia, a tense relationship began to heal
Thwarted Bingaman Still Eyeing Clean Energy Standard in Next Congress
Head of the Federal Aviation Administration to resign, allowing Trump to pick his successor
The FDA approves an Alzheimer's drug that appears to modestly slow the disease
Can Trump Revive Keystone XL? Nebraskans Vow to Fight Pipeline Anew
The FDA no longer requires all drugs to be tested on animals before human trials